Literature DB >> 28045852

Overview on Criteria for MEP Monitoring.

David B MacDonald1.   

Abstract

Intraoperative motor evoked potentials include the D-wave as a surrogate for long-term motor outcome and muscle motor evoked potentials as a surrogate for early outcome. Their efficacy depends on excluding confounding factors and on warning criteria; insufficiently sensitive criteria could result in unpredicted deficits, whereas excessively sensitive ones could cause false alarms deterring surgical treatment and jading surgeons to alerts, eventually leading to deficits through failure to intervene. Although D-waves have few indications, they are nonsynaptic, linear, and stable-properties that support amplitude reduction criteria: >50% for intramedullary spinal cord tumor surgery and >30% to 40% for peri-Rolandic brain surgery. Muscle motor evoked potentials have many indications but are polysynaptic, nonlinear, and unstable-properties that challenge warning criteria and make them unusually capricious and sensitive. Disappearance is a remarkably frequent pathologic sign compared with other evoked potentials and is always a major criterion. Marked (>80%) amplitude reduction may be a minor or moderate spinal cord criterion, depending on the surgical circumstance. Modest (>50%) reduction may be a major criterion for brain, brainstem, and facial nerve monitoring, if justified by sufficient preceding stability. Acute ≥100-V threshold elevation may be a minor or moderate spinal cord criterion, depending on the surgical circumstance and on adherence to reported methodology. Morphology criteria lack support. Tailoring warning criteria to different monitoring situations based on anatomy, surgical goals, and published evidence seems advisable.

Entities:  

Mesh:

Year:  2017        PMID: 28045852     DOI: 10.1097/WNP.0000000000000302

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  7 in total

1.  Effect of ketamine on transcranial motor-evoked potentials during spinal surgery: a pilot study.

Authors:  Stephanie Lam; Masanori Nagata; Sonia K Sandhu; Robert A Veselis; Patrick J McCormick
Journal:  Br J Anaesth       Date:  2019-10-07       Impact factor: 9.166

Review 2.  Thermal Protection Strategies and Neuromonitoring during Ablation.

Authors:  Alan Alper Sag; Aatif M Husain
Journal:  Semin Intervent Radiol       Date:  2022-06-30       Impact factor: 1.780

3.  Efficacy of evoked potential monitoring for predicting postoperative motor status in internal carotid artery aneurysm surgeries.

Authors:  Hao You; Xing Fan; Dongze Guo; Zhibao Li; Xiaorong Tao; Lei Qi; Miao Ling; Jiajia Liu; Hui Qiao
Journal:  J Clin Monit Comput       Date:  2021-03-23       Impact factor: 1.977

4.  Surgeon-Directed Neuromonitoring in Adolescent Spinal Deformity Surgery Safely Assesses Neurological Function.

Authors:  Andrea Chan; Purnajyoti Banerjee; Cristina Lupu; Tim Bishop; Jason Bernard; Darren Lui
Journal:  Cureus       Date:  2021-11-23

5.  Transcranial versus direct electrical stimulation for intraoperative motor-evoked potential monitoring: Prognostic value comparison in asleep brain tumor surgery.

Authors:  Luca Viganò; Vincenzo Callipo; Marta Lamperti; Marco Rossi; Marco Conti Nibali; Tommaso Sciortino; Lorenzo Gay; Guglielmo Puglisi; Antonella Leonetti; Gabriella Cerri; Lorenzo Bello
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

6.  Intramedullary spinal cord cavernous malformations-association between intraoperative neurophysiological monitoring changes and neurological outcome.

Authors:  Sebastian Niedermeyer; Andrea Szelenyi; Christian Schichor; Joerg-Christian Tonn; Sebastian Siller
Journal:  Acta Neurochir (Wien)       Date:  2022-09-06       Impact factor: 2.816

7.  The influence of depth of anesthesia and blood pressure on muscle recorded motor evoked potentials in spinal surgery. A prospective observational study protocol.

Authors:  Sebastiaan E Dulfer; M M Sahinovic; F Lange; F H Wapstra; D Postmus; A R E Potgieser; C Faber; R J M Groen; A R Absalom; G Drost
Journal:  J Clin Monit Comput       Date:  2021-01-28       Impact factor: 2.502

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.